Building Lactams by a Driven Highly Selective and General Deoxygenative Hydrogenation of Cyclic Imides Using an Alumina Supported AgRe Bimetallic Nanocatalyst

Jose R. Cabrero-Antonino,Carles Lluna-Galán,Juan Camilo Arango-Daza,Daviel Gómez,Patricia Concepción,Rong Sun,José J. Calvino,Laura Simonelli,Rosa Adam
DOI: https://doi.org/10.26434/chemrxiv-2024-495wv
2024-10-21
Abstract:The rational design of robust nanocatalysts containing the suitable active sites for building relevant organic compounds, such as lactams, is a desired approximation towards the development of a sustainable fine chemistry field. In that sense, the design of a proper nanomaterial able to mediate the selective hydrodeoxygenation of cyclic imides to lactams with high tolerance to the preservation of aromatic rings remains rather unexplored. Here, we have been able to design a bimetallic AgRe nanomaterial with excellent activity and selectivity to mediate this transformation affording more than 60 lactams from the corresponding imides. Interestingly, we have disclosed that the optimal AgRe nanocatalyst is constituted by AgReO4 nanoaggregates that undergo an in situ hydrogenative dispersion to form the active centers composed by Ag(0) nanoparticles and ReOx species. Deep characterization, together with kinetic and mechanistic studies, have revealed that the intimate Ag-Re contact intrinsic to AgReO4 species is key for the formation of the most active catalytic sites and the proper bimetallic cooperation required for mediating the desired process.
Chemistry
What problem does this paper attempt to address?
The main problem this paper attempts to address is the design of an efficient heterogeneous nanocatalyst for the selective hydrogenation and deoxygenation of cyclic imides (especially phthalimides) to prepare the corresponding lactams with high selectivity and activity. Specifically, the research aims to develop a catalyst that can effectively activate cyclic imides and control their selective hydrogenation while preserving the aromatic ring from reduction. Through this process, various lactam compounds with significant medicinal value can be synthesized. The paper mentions that although there are currently some methods to achieve the hydrogenation of cyclic imides, most of these methods suffer from poor selectivity, numerous by-products, or insufficient tolerance to aromatic rings. Therefore, designing a catalyst that can efficiently and selectively convert cyclic imides to lactams under mild conditions is of great significance for the fields of medicinal chemistry and fine chemicals.